Circulation

Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke.

Circulation

Sun YP, Zhu BQ, Sievers RE, Glantz SA, Parmley WW

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

Circulation

Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM

Exposure to environmental tobacco smoke increases myocardial infarct size in rats.

Circulation

Zhu BQ, Sun YP, Sievers RE, Glantz SA, Parmley WW, Wolfe CL

Setting the policy, education, and research agenda to reduce tobacco use. Workshop I. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health.

Circulation

Becker DM, Windsor R, Ockene JK, Berman B, Best JA, Cummings KM, Glantz S, Haynes S, Henningfield J, Novotny TE

LDL subclass phenotypes and the insulin resistance syndrome in women.

Circulation

Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM

Effect of disrupting the mitral apparatus on left ventricular function in dogs.

Circulation

Shintani H, Glantz SA

Passive smoking and heart disease. Epidemiology, physiology, and biochemistry.

Circulation

Glantz SA, Parmley WW

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Circulation

Austin MA, King MC, Vranizan KM, Krauss RM

Volume conductance catheter.

Circulation

Glantz SA, Boltwood CM, Appleyard RF, Applegate RJ, Cheng CP, Little WC

Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men.

Circulation

Williams PT, Krauss RM, Vranizan KM, Wood PD

Pages

Important Dates

SECOND CYCLE NOW CLOSED

CHIC-CFAR Symposium: Wednesday, Sept 25, 2019

Laurence Huang, MD

Clinical Professor

Medicine

I am a pulmonary and critical care medicine specialist with a research focus on pulmonary diseases affecting persons with HIV with a global perspective. I am a clinical-translational researcher with clinical cohorts in San Francisco, CA and in Kampala, Uganda.

Priscilla Hsue, MD

Professor and Chief

Medicine

Professional Experience: Dr. Hsue trained in Internal Medicine in the Molecular Medicine Training Program at UC San Francisco and in Cardiovascular Medicine at UC San Francisco. She served as Chief Cardiology Fellow during this time. She has been on the faculty in the Department of Medicine at San Francisco General Hospital since 2002. She started the HIV Cardiology Clinic since March 2004 at the Positive Health Program at Ward 86, which is one of the first subspeciality clinics of its kind in the nation.